Pharmaceutics

Faculty

Photo

Stavchansky, Salomon A., Ph.D.
Professor of Pharmaceutics
Alcon Centennial Professor
PHR 4.214C
512-471-1407
stavchansky@austin.utexas.edu


Research Interests

Generic and chemical class therapeutic substitution are changing the delivery of medicines. If different products are therapeutically equivalent it makes sense to allow the use of the cheaper alternative. Thus, the Food and Drug Administration as well as the pharmaceutical industry are extremely interested in answering the question of whether switching a patient from one drug product to another will result in the same therapeutic efficacy and safety profile. The primary mission of our laboratories is to apply the principles of biopharmaceutics, pharmacokinetics, and drug metabolism to evaluate and design drug delivery systems to ensure the safety and efficacy of drug products. This involves the development of sensitive and selective analytical methodology to quantitatively measure the concentration of drugs in biological systems and to better understand the relationship between drug solubility and drug permeability through biological membranes. We have initiated research in the pharmacokinetic ev luation and delivery of oligonucleotides. Graduate students and research assistants acquire knowledge in the areas of physical and analytical chemistry, statistics, data processing, computer assisted pharmacokinetics and in the experimental design of clinical protocols. Grants and contracts from the government and the pharmaceutical industry provide our state-of-the-art laboratory equipment.


(Download PDF Reader.)

Last Reviewed: October 2, 2008

Division Information

Mailing Address:
Pharmaceutics Division
College of Pharmacy
The University of Texas
at Austin
2409 University Ave.
Stop A1900
Austin, TX, USA
78712-1113

Email Address: pharmacy
@austin.utexas.edu

Phone:
1-512-471-7182


Researchers Offer Promise Through Enhanced Drug Delivery

Enhancing drug-delivery technologies can help in curing and treating diseases such as cancer, cardiovascular diseases, diabetes, fungal, respiratory and infectious diseases and treatment after organ transplants to prevent rejection.

> Read more about this story.


index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z